nanomaterials based sensors for acetaminophen and dopamine detection
DESCRIPTION
Nanomaterials Based Sensors for Acetaminophen and Dopamine Detection. Luminiţa Fritea , Cecilia Cristea , Mihaela Tertiş, Oana Hosu, Robert Săndulescu Analytical Chemistry Department, Faculty of Pharmacy, - PowerPoint PPT PresentationTRANSCRIPT
Correlation between Nyquist plots for: (A) bare GCE and (B) SWCNT+PEI+HRP modified GCE in 10 mM K3[Fe(CN)6] + K4[Fe(CN)6], in phosphate buffer (0.1 M; pH 7.4). Amplitude: 10
mV, first frq 100 kHz last frq 10 mHz. Fitting results are given by lines. Inset: the equivalent circuits used .
0 200 400 600 800 1000 1200 1400 1600-3.0
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
b
a
time (s)
I /
A
GCE15 layers
= CNT
GCE
GCE
= PEI
= HRP
GCE
Nanomaterials Based Sensors for Acetaminophen and Dopamine Detection
Luminiţa Fritea, Cecilia Cristea, Mihaela Tertiş, Oana Hosu, Robert SăndulescuAnalytical Chemistry Department, Faculty of Pharmacy,
“Iuliu Haţieganu” University of Medicine and Pharmacy, Pasteur 4 Cluj-Napoca, Romania, [email protected]
CONCLUSIONS
The combination of different types of nanomaterials (CNTs, graphenes, cyclodextrins) and polymers as immobilization platform with different bioreceptors reveals enhanced electroanalytical performances of the sensors in the pharmaceutical and biomedical analysis. The obtained biosensors present good sensitivity and selectivity for the detection of various pharmaceuticals.
Amperometric response for dopamine on β-CD+PPO+PEI-GO/GCE (a) and bare GCE (b); tyrosinase concentration: 1 mg/mL; PEI 1mg/mL;
LOD: 10.42 μMLDR: 30-2500 μM
GCE GCE
-CYCLODEXTRINE PEI DOPAMINEGRAPHENE
GCE GCE
-CYCLODEXTRINE PEI DOPAMINEGRAPHENE
GCE GCE
-CYCLODEXTRINE PEI DOPAMINEGRAPHENE
A. Acetaminophen biosensor based on carbon nanotubes and horseradish peroxidase (HRP)
This paper was elaborated under the frame of European Social Found, Human Resources Development Operational Programme 2007-2013, projects no. POSDRU/159/1.5/S/138776 and 159/1.5/S/136893.The authors are grateful for the financial support to the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, project number PN-II-ID-PCE-2011-3-0355.
0.0 0.5 1.0 1.5 2.0 2.5
0.0
0.5
1.0
1.5
2.0
2.5
Rct CPE
Cdl Rads Rref
Cref
Rsol
Cabs
Z'/k
-Z"/
k
0 200 400 600 800 1000 1200 1400
-0.40
-0.35
-0.30
-0.25
-0.20
I /
A
time (s)
Amperometric response for acetaminophen on GCE (d=1 mm) modified with HRP/SWCNT/PEI film; HRP concentration: 0.3 mg mL-1 and 0.6 mg mL-1 in PEI 1 mg mL-1
(A) SWVs registered on: bare GCE (a); PPO(1mg/ml)+PEI(1mg/ml) (1 layer) modified GCE (b); β-CD (1mg/ml) (1 layer) + PPO + PEI (1 layer)/GCE (c); PPO+ PEI (1 layer) GO (LBL; 3 layers)/GCE (d); β-CD (1 layer) + PPO + PEI (1 layer) g GO (LBL; 3 layers)/GCE (e) in the presence of 1 mM dopamine solution in PB solution (0.1M; pH 7.2).
(B) EIS spectra (61 frq. 100kHz -10 mHz; amplitude: 0.01 V) registered for: bare GCE (a); and modified with: graphene oxide (GO) by spin coating (b); GO through layer by layer deposition - 3 layers (c) and GCE modified with GO through LBL deposition and β-CD (d) in the presence of 10 mM [Fe(CN)6]3-/4- in PBS (0.1 M; pH 7.2);
-0.2 0.0 0.2 0.4 0.6 0.80
5
10
15
20
25
30
ed
c
b
a
E (V / Ag/AgCl(KCl))
I /
A
B. Dopamine biosensor with graphene and tyrosinase (PPO)
o Schematic representation for the development of acetaminophen and dopamine biosensors
o Real sample analysis – acetaminophen determination in pharmaceutical products
(A) (B)
(D) (E)
0 5 10 15 20 25 30 35
0
5
10
15
20
25
30
35
W Rct
CPE Rsol
-Z"/
k
Z'/k
(B)(A)
o Biosensor testing - amperometry
LOD: 1.36–8.09 μMLDR: 4 - 80 μM; 20 - 160 μM
0 2 4 6 8 10 12
0
1
2
3
4
5
6
d
c b a
Z' / k
-Z'' /
k
(A) (B)
o Electrochemical characterization of modified glassy carbon electrodes and biosensors optimization
Different types of electrochemical biosensors are reported based on nanomaterials like carbon nanotubes (SWCNT), graphenes, cyclodextrines (β-CD) and conductive polymers (polyethylenimine - PEI). Two model molecules, acetaminophen and dopamine were detected with those biosensors.
Electrode type Pharmaceutical samplesSamples
acetaminophen concentration (μM)
Added(μM)
Found(μM)
Recovery(%)
RSD(%)
0.3mg HRP/mlPEI /SWCNT(15layer)/GCE
PANADOL 500 mg(GlaxoSmithKline)
101010
-1020
10.0420.8831.09
100.40104.40103.64
1.671.312.04
SANADOR 500 mg(S.C.Laropharm S.R.L.)
101010
-1020
9.9419.7728.97
99.4498.8596.60
2.352.542.09
0.6mg HRP/mlPEI /SWCNT(15layer)/GCE
PANADOL 500 mg(GlaxoSmithKline)
101010
-1020
9.9718.0426.89
99.7090.0289.64
1.972.432.56
SANADOR 500 mg(S.C.Laropharm S.R.L.)
101010
-1020
9.8918.6628.24
98.9093.3294.15
1.051.641.87
Measurement results for acetaminophen in pharmaceutical samples
Acetaminophen Dopamine
The acetaminophen
indirect detection mechanism –
catalytic peroxydation through HRP OH
NH
CH3C O
N
CH3C O
OOH
NH
CH3C O
+ H2O2 + 2 H+ + HRP
- 2 H2O
+ 2 e- + 2 H+
acetaminophen N-acetyl-p-benzochinoneimine